HomeFull speed ahead. Keep track of advancements in every frontier

TheTechno Optimist.

PAI-1 inhibitorJuvenescence—

Juvenescence

Longevity drugs, PAI-1 blocker

GBprivateest. 2017juvlabs.com (opens juvlabs.com)Checked 25 Sep

The brief

Analyst view
  • Its PAI-1 blocker finished its first trial in Jan 2026 as a once-a-day pill; a Phase 2 test is planned for later in 2026.
  • Abu Dhabi health group M42 invested and partnered on AI drug discovery in Jul 2026.
Programs

Juvenescence, one program

Updated 1 Jan 2026
PAI-1 inhibitorA pill that blocks PAI-1, a protein that rises with age and is linked to scarring, blood clots and worn-out cells. People born with a broken PAI-1 gene live longer on average.ProtoNextPhase 2 starts · 2026Updated 1 Jan 2026View program →
Research · Proto · Pilot · Deploy · Scaling

Peers

Anti-aging drugs · 3

Company & funding

HQ
GB
Founded
2017

Partners & customers

1 investor

People

Key people
Primer